Increase in apoptotic effect of panax ginseng by microwave processing in human prostate cancer cells: In vitro and in vivo studies

Journal of Ginseng Research

Volumn 40, Issue 1, 2016, Pages 62-67

  Park, Jun Yeon ^a   Choi, Pilju ^b   Kim, Ho Kyong ^c   Kang, Ki Sung ^a   Ham, Jungyeob ^b  

^a Gachon University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Richwood Pharmaceutical Company   (South Korea)

Author keywords

Anticancer; Ginsenoside; Microwave; Panax ginseng; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE 20 R; GINSENOSIDE 20 S; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 3; GINSENOSIDE RG 5; GINSENOSIDE RK 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DRUG ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; LNCAP CELL LINE; MALE; MICROWAVE RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84954197565     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2015.04.007     Document Type: Article

References (31)

1. Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-864.
2. Bidoli E, Talamini R, Bosetti C, Negri E, Maruzzi D, Montella M, Franceschi S, La Vecchia C. Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 2005;16:152-157.
3. Garnick MB, Fair WR. Combating prostate cancer. Sci Am 1998;279:74-83.
4. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 1997;51:193-200.
5. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278:1073-1077.
6. Belaiche P, Lievoux O. Clinical studies on the palliative treatment of prostatic adenoma with extract of Urtica root. Phytother Res 1991;5:267-269.
7. Bhanot A, Sharma R, Noolvi MN. Natural sources as potential anti-cancer agents: a review. Int J Phytomedicine 2011;3:9-26.
8. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461-477.
9. Lee HW, Jang KS, Choi HJ, Jo A, Cheong JH, Chun KH. Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy. BMB Rep. 2014;47: 697-702.
10. Kang KS, Ham J, Kim YJ, Park JH, Cho EJ, Yamabe N. Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism. J Ginseng Res 2013;37:379-388.
11. Kang KS, Yokozawa T, Yamabe N, Kim HY, Park JH. ESR study on the structure and hydroxyl radical-scavenging activity relationships of ginsenosides isolated from Panax ginseng C A Meyer. Biol Pharm Bull 2007;30:917-921.
12. Kim YJ, Yamabe N, Choi P, Lee jW, Ham J, Kang KS. Efficient thermal degly-cosylation of ginsenoside Rd and its contribution to the improved anticancer activity of ginseng. J Agric Food Chem 2013;61:9185-9191.
13. Choi P, Park JY, Kim T, Park SH, Kim H, Kang KS, Ham J. Improved anticancer effect of ginseng extract by microwave-assisted processing through the generation of ginsenosides Rg3, Rg5 and Rk1. J Funct Foods 2015;14:613-622.
14. Yamabe N, Kim YJ, Lee S, Cho EJ, Park SH, Ham J, Kim HY, Kang KS. Increase in antioxidant and anticancer effects of ginsenoside Re-lysine mixture by Mail-lard reaction. Food Chem 2013;138:876-883.
15. Jang HJ, Han IH, Kim YJ, Yamabe N, Lee D, Hwang GS, Oh M, Choi KC, Kim SN, Ham J, et al. Anticarcinogenic effects of products of heat-processed ginseno-side Re, a major constituent of ginseng berry, on human gastric cancer cells. J Agric Food Chem 2014;62:2830-2866.
16. Kim AD, Kang KA, Kim HS, Kim DH, Choi YH, Lee SJ, Kim HS, Hyun JW. A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis 2013;4:e750.
17. Kim DG, Jung KH, Lee DG, Yoon JH, Choi KS, Kwon SW, Shen HM, Morgan MJ, Hong SS, Kim YS. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget 2014;5:4438-4451.
18. Liang LD, He T, Du TW, Fan YG, Chen DS, Wang Y. Ginsenoside Rg5 induces apoptosis and DNA damage in human cervical cancer cells. Mol Med Rep 2015;11:940-946.
19. Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011;10:1533-1541.
20. Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell 2011;19:664-678.
21. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension ofdefective response to DNA damage. DNA Repair(Amst) 2002;22: 3-25.
22. Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 2007;43:332-347.
23. Naka K, Muraguchi T, Hoshii T, Hirao A. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal 2008;10:1883-1894.
24. Jang JH, Cho YC, Kim KH, Lee KS, Lee J, Kim DE, Park JS, Jang BC, Kim S, Kwon TK, et al. BAI, a novel Cdk inhibitor, enhances farnesyltransferase inhibitor LB42708-mediated apoptosis in renal carcinoma cells through the downregulation of Bcl-2 and c-FLIP (L). Int J Oncol 2014;45:1680-1690.
25. Murphy LL, Rice JA, Zong W. Ginsenosides Rc and Rh2 inhibit MCF-7 cell proliferation through distinctly different mechanisms. Mol Biol Cell 2001;12(Suppl):764.
26. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999;14:869-875.
27. Park JA, Lee KY, Oh YJ, Kim KW, Lee SK. Activation of caspase-3-protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 1997;121:73-81.
28. Clingen PH, Wu JY, Miller J, Mistry N, Chin F, Wynne P, Prise KM, Hartley JA. Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy. Biochem Pharmacol 2008;76:19-27.
29. Mah LJ, El-Osta A, Karagiannis TC. GammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010;24:679-86.
30. Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG. Tyrosine dephos-phorylation of H2AX modulates apoptosis and survival decisions. Nature 2009;458:591-596.
31. Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anti-cancer therapy. Nat Rev Clin Oncol 2011;8:528-539.